<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="different compared with that of PHHs, as the addition of" exact="dimethyl sulfoxide" post="(DMSO) plus polyethylene glycol 8000 (PEG8000) during infection does"/>
 <result pre="vena cava under anaesthesia by intraperitoneal injection of 30 mg/kg" exact="pentobarbital" post="sodium (7). Death was confirmed by respiratory arrest, cardiac"/>
 <result pre="plates pre-coated with collagen (Gibco; Thermo Fisher Scientific, Inc.) in" exact="dimethyl sulfoxide" post="(DMSO)-free primary human hepatocyte maintenance medium (PMM) (4) containing"/>
 <result pre="supplemented with 10% FBS, 100 U/ml penicillin and 100 µg/ml" exact="streptomycin" post="maintained at 37°C in a 5% CO2 incubator. Huh7D"/>
 <result pre="(DMEM supplemented with 5% FBS, 100 U/ml penicillin, 100 µg/ml" exact="streptomycin" post="and 2.5% DMSO) for 24–72 h prior to HBV"/>
 <result pre="supplemented with 10% FBS, 100 U/ml penicillin and 100 µg/ml" exact="streptomycin" post="maintained at 37°C in a 5% CO2 incubator. For"/>
 <result pre="penicillin and 100 µg/ml streptomycin, 5 µg/ml insulin, 18 ng/ml" exact="hydrocortisone" post="and 2–2.5% DMSO. The culture media was collected at"/>
 <result pre="~50 nM. The less effective inhibition of HBV infection by" exact="lamivudine" post="possibly occurred due to the failure of lamivudine to"/>
 <result pre="infection by lamivudine possibly occurred due to the failure of" exact="lamivudine" post="to block HBV entry. These results indicated that HBV-infected"/>
</results>
